{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T17:48:18Z","timestamp":1766598498981},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:00:00Z","timestamp":1487116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Generalized anxiety disorder (GAD) is a common chronic condition that is understudied compared to other psychiatric disorders. An altered adrenergic function has been reported in GAD, however direct evidence for genetic susceptibility is missing. This study evaluated the associations of gene variants in adrenergic receptors (<jats:italic>ADRs<\/jats:italic>) with GAD, with the involvement of stressful events. Data were obtained from 844 French community-dwelling elderly aged 65 or over. Anxiety disorders were assessed using the Mini-International Neuropsychiatry Interview, according to DSM-IV criteria. Eight single-nucleotide polymorphisms (SNPs) involved with adrenergic function were genotyped; adrenergic receptors alpha(1A) (<jats:italic>ADRA1A<\/jats:italic>), alpha(2A) (<jats:italic>ADRA2A<\/jats:italic>), and beta2 (<jats:italic>ADRB2<\/jats:italic>) and transcription factor <jats:italic>TCF7L2<\/jats:italic>. Questionnaires evaluated recent stressful life events as well as early environment during childhood and adolescence. Using multivariate logistic regression analyses four SNPs were significantly associated with GAD. A 4-fold modified risk was found with <jats:italic>ADRA1A rs17426222<\/jats:italic> and <jats:italic>rs573514,<\/jats:italic> and <jats:italic>ADRB2 rs1042713<\/jats:italic> which remained significant after Bonferroni correction. Certain variants may moderate the effect of adverse life events on the risk of GAD. Replication in larger samples is needed due to the small case number. This is the first study showing that <jats:italic>ADR<\/jats:italic> variants are susceptibility factors for GAD, further highlighting the critical role of the adrenergic nervous system in this disorder.<\/jats:p>","DOI":"10.1038\/srep42676","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T11:35:37Z","timestamp":1487158537000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Preliminary evidence for a role of the adrenergic nervous system in generalized anxiety disorder"],"prefix":"10.1038","volume":"7","author":[{"given":"Xiaobin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Norton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Carri\u00e8re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Chaudieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Laure","family":"Ancelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,15]]},"reference":[{"key":"BFsrep42676_CR1","first-page":"37","volume":"345","author":"EA Hoge","year":"2012","unstructured":"Hoge, E. A., Ivkovic, A. & Fricchione, G. L. Generalized anxiety disorder: diagnosis and treatment. Brit. Med. J. 345, 37\u201342 (2012).","journal-title":"Brit. Med. J."},{"key":"BFsrep42676_CR2","first-page":"24","volume":"172C","author":"X Zhang","year":"2014","unstructured":"Zhang, X. et al. Generalized anxiety in community-dwelling elderly: Prevalence and clinical characteristics. J. Affect. Disord. 172C, 24\u201329 (2014).","journal-title":"J. Affect. Disord."},{"key":"BFsrep42676_CR3","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.2174\/138161212803530781","volume":"18","author":"K Domschke","year":"2012","unstructured":"Domschke, K. & Deckert, J. Genetics of anxiety disorders - status quo and quo vadis. Curr. Pharm. Des. 18, 5691\u20135698 (2012).","journal-title":"Curr. Pharm. Des"},{"key":"BFsrep42676_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/archgenpsychiatry.2011.1385","volume":"69","author":"CE Sartor","year":"2012","unstructured":"Sartor, C. E. et al. Common heritable contributions to low-risk trauma, high-risk trauma, posttraumatic stress disorder, and major depression. Arch. Gen. Psychiatry 69, 293\u2013299 (2012).","journal-title":"Arch. Gen. Psychiatry"},{"key":"BFsrep42676_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ajmg.b.10013","volume":"117B","author":"A Tadic","year":"2003","unstructured":"Tadic, A. et al. Association of a MAOA gene variant with generalized anxiety disorder, but not with panic disorder or major depression. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 117B, 1\u20136 (2003).","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet"},{"key":"BFsrep42676_CR6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00041444-200503000-00002","volume":"15","author":"J-S You","year":"2005","unstructured":"You, J.-S., Hu, S.-Y., Chen, B. & Zhang, H.-G. Serotonin transporter and tryptophan hydroxylase gene polymorphisms in Chinese patients with generalized anxiety disorder. Psychiatr. Genet. 15, 7\u201311 (2005).","journal-title":"Psychiatr. Genet."},{"key":"BFsrep42676_CR7","doi-asserted-by":"crossref","first-page":"e536","DOI":"10.1038\/tp.2015.31","volume":"5","author":"X Zhang","year":"2015","unstructured":"Zhang, X. et al. Risk factors for late-onset generalized anxiety disorder: results from a 12-year prospective cohort (The ESPRIT study). Transl. Psychiatry 5, e536 (2015).","journal-title":"Transl. Psychiatry"},{"key":"BFsrep42676_CR8","doi-asserted-by":"crossref","first-page":"5663","DOI":"10.2174\/138161212803530907","volume":"18","author":"C Faravelli","year":"2012","unstructured":"Faravelli, C. et al. The role of life events and HPA axis in anxiety disorders: a review. Curr. Pharm. Des. 18, 5663\u20135674 (2012).","journal-title":"Curr. Pharm. Des"},{"key":"BFsrep42676_CR9","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jad.2014.01.022","volume":"158","author":"K Hilbert","year":"2014","unstructured":"Hilbert, K., Lueken, U. & Beesdo-Baum, K. Neural structures, functioning and connectivity in Generalized Anxiety Disorder and interaction with neuroendocrine systems: a systematic review. J. Affect. Disord. 158, 114\u2013126 (2014).","journal-title":"J. Affect. Disord."},{"key":"BFsrep42676_CR10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1159\/000026677","volume":"42","author":"G Gerra","year":"2000","unstructured":"Gerra, G. et al. Neuroendocrine responses to psychological stress in adolescents with anxiety disorder. Neuropsychobiology 42, 82\u201392 (2000).","journal-title":"Neuropsychobiology"},{"key":"BFsrep42676_CR11","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.bi.60.070191.003253","volume":"60","author":"H Dohlman","year":"1991","unstructured":"Dohlman, H., Thorner, J., Caron, M. & Lefkowitz, R. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60, 653\u2013688 (1991).","journal-title":"Annu. Rev. Biochem."},{"key":"BFsrep42676_CR12","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1177\/0269881109359099","volume":"25","author":"SD Hood","year":"2011","unstructured":"Hood, S. D. et al. Noradrenergic function in generalized anxiety disorder: impact of treatment with venlafaxine on the physiological and psychological responses to clonidine challenge. J. Psychopharmacol. 25, 78\u201386 (2011).","journal-title":"J. Psychopharmacol."},{"key":"BFsrep42676_CR13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hup.1171","volume":"26","author":"MU Shad","year":"2011","unstructured":"Shad, M. U., Suris, A. M. & North, C. S. Novel combination strategy to optimize treatment for PTSD. Hum. Psychopharmacol 26, 4\u201311 (2011).","journal-title":"Hum. Psychopharmacol"},{"key":"BFsrep42676_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1192\/bjp.184.2.147","volume":"184","author":"K Ritchie","year":"2004","unstructured":"Ritchie, K. et al. Prevalence of DSM-IV psychiatric disorder in the French elderly population. Br. J. Psychiatry 184, 147\u2013152 (2004).","journal-title":"Br. J. Psychiatry"},{"key":"BFsrep42676_CR15","doi-asserted-by":"crossref","unstructured":"The 3C Study Group. Vascular factors and risk of dementia: design of the Three-City Study and baseline characteristics of the study population. Neuroepidemiology 22, 316\u2013325 (2003).","DOI":"10.1159\/000072920"},{"key":"BFsrep42676_CR16","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein, M. F., Folstein, S. E. & McHugh, P. R. \u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12, 189\u2013198 (1975).","journal-title":"J. Psychiatr. Res."},{"key":"BFsrep42676_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/ageing\/27.6.707","volume":"27","author":"RH Harwood","year":"1998","unstructured":"Harwood, R. H., Prince, M. J., Mann, A. H. & Ebrahim, S. The prevalence of diagnoses, impairments, disabilities and handicaps in a population of elderly people living in a defined geographical area: the Gospel Oak project. Age. Ageing 27, 707\u2013714 (1998).","journal-title":"Age. Ageing"},{"key":"BFsrep42676_CR18","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.4088\/JCP.08m04510","volume":"70","author":"K Ritchie","year":"2009","unstructured":"Ritchie, K. et al. Association of adverse childhood environment and 5-HTTLPR Genotype with late-life depression. J. Clin. Psychiatry 70, 1281\u20131288 (2009).","journal-title":"J. Clin. Psychiatry"},{"key":"BFsrep42676_CR19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0924-9338(97)83296-8","volume":"12","author":"Y Lecrubier","year":"1997","unstructured":"Lecrubier, Y. et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: reliability and validity according to the CIDI. Eur. Psychiatry. 12, 224\u2013231 (1997).","journal-title":"Eur. Psychiatry."},{"key":"BFsrep42676_CR20","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S0924-9338(97)83297-X","volume":"12","author":"D Sheehan","year":"1997","unstructured":"Sheehan, D. et al. The validity of the Mini International Neuropsychiatric Interview (MINI) according to the SCID-P and its reliability. Eur. Psychiatry. 12, 232\u2013241 (1997).","journal-title":"Eur. Psychiatry."},{"key":"BFsrep42676_CR21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1176\/appi.ajp.2013.12091235","volume":"170","author":"K Ritchie","year":"2013","unstructured":"Ritchie, K., Norton, J., Mann, A., Carriere, I. & Ancelin, M. L. Late-onset agoraphobia: general population incidence and evidence for a clinical subtype. Am. J. Psychiatry 170, 790\u2013798 (2013).","journal-title":"Am. J. Psychiatry"},{"key":"BFsrep42676_CR22","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV. (American Psychiatric Press, Washington, DC., 1994)."},{"key":"BFsrep42676_CR23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.biopsych.2005.04.051","volume":"58","author":"DA Clark","year":"2005","unstructured":"Clark, D. A. et al. Polymorphisms in the promoter region of the alpha1A-adrenoceptor gene are associated with schizophrenia\/schizoaffective disorder in a Spanish isolate population. Biol. Psychiatry 58, 435\u2013439 (2005).","journal-title":"Biol. Psychiatry"},{"key":"BFsrep42676_CR24","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/YPG.0b013e32832a5043","volume":"19","author":"J Elia","year":"2009","unstructured":"Elia, J. et al. Candidate gene analysis in an on-going genome-wide association study of attention-deficit hyperactivity disorder: suggestive association signals in ADRA1A. Psychiatr. Genet. 19, 134\u2013141 (2009).","journal-title":"Psychiatr. Genet."},{"key":"BFsrep42676_CR25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/tpj.2009.55","volume":"10","author":"YR Liu","year":"2010","unstructured":"Liu, Y. R. et al. ADRA1A gene is associated with BMI in chronic schizophrenia patients exposed to antipsychotics. Pharmacogenomics. J 10, 30\u201339 (2010).","journal-title":"Pharmacogenomics. J"},{"key":"BFsrep42676_CR26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1471-2261-8-40","volume":"8","author":"SR Freitas","year":"2008","unstructured":"Freitas, S. R., Pereira, A. C., Floriano, M. S., Mill, J. G. & Krieger, J. E. Association of alpha1a-adrenergic receptor polymorphism and blood pressure phenotypes in the Brazilian population. BMC. Cardiovasc. Disord 8, 40 (2008).","journal-title":"BMC. Cardiovasc. Disord"},{"key":"BFsrep42676_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.psychres.2012.08.003","volume":"205","author":"J Lochman","year":"2013","unstructured":"Lochman, J., Balcar, V. J., Stastny, F. & Sery, O. Preliminary evidence for association between schizophrenia and polymorphisms in the regulatory Regions of the ADRA2A, DRD3 and SNAP-25 Genes. Psychiatry. Res. 205, 7\u201312 (2013).","journal-title":"Psychiatry. Res."},{"key":"BFsrep42676_CR28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.b.10056","volume":"118B","author":"DE Comings","year":"2003","unstructured":"Comings, D. E., Gonzalez, N. S., Cheng Li, S. C. & MacMurray, J. A \u201cline item\u201d approach to the identification of genes involved in polygenic behavioral disorders: the adrenergic alpha2A (ADRA2A) gene. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 118B, 110\u2013114 (2003).","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet"},{"key":"BFsrep42676_CR29","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1038\/npp.2009.81","volume":"34","author":"N Perroud","year":"2009","unstructured":"Perroud, N. et al. Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 34, 2517\u20132528 (2009).","journal-title":"Neuropsychopharmacology"},{"key":"BFsrep42676_CR30","doi-asserted-by":"crossref","first-page":"e6034","DOI":"10.1371\/journal.pone.0006034","volume":"4","author":"S Sober","year":"2009","unstructured":"Sober, S. et al. Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array. PLoS One 4, e6034 (2009).","journal-title":"PLoS One"},{"key":"BFsrep42676_CR31","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1210\/me.2008-0135","volume":"22","author":"T Jin","year":"2008","unstructured":"Jin, T. & Liu, L. Minireview: The Wnt signaling pathway effector TCF7L2 and type 2 diabetes mellitus. Mol. Endocrinol. 22, 2383\u20132392 (2008).","journal-title":"Mol. Endocrinol."},{"key":"BFsrep42676_CR32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.molmet.2015.03.002","volume":"4","author":"A Migliorini","year":"2015","unstructured":"Migliorini, A. & Lickert, H. Beyond association: A functional role for Tcf7l2 in \u03b2-cell development. Mol Metab 4, 365\u2013366 (2015).","journal-title":"Mol Metab"},{"key":"BFsrep42676_CR33","doi-asserted-by":"crossref","first-page":"e111350","DOI":"10.1371\/journal.pone.0111350","volume":"9","author":"C Faisy","year":"2014","unstructured":"Faisy, C. et al. Wnt\/beta-catenin signaling modulates human airway sensitization induced by beta2-adrenoceptor stimulation. PLoS One 9, e111350 (2014).","journal-title":"PLoS One"},{"key":"BFsrep42676_CR34","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.biopsych.2011.01.031","volume":"70","author":"T Hansen","year":"2011","unstructured":"Hansen, T. et al. At-risk variant in TCF7L2 for type II diabetes increases risk of schizophrenia. Biol. Psychiatry 70, 59\u201363 (2011).","journal-title":"Biol. Psychiatry"},{"key":"BFsrep42676_CR35","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMoa062418","volume":"355","author":"JC Florez","year":"2006","unstructured":"Florez, J. C. et al. TCF7L2 polymorphisms and progression to diabetes in the Diabetes Prevention Program. N. Engl. J. Med. 355, 241\u2013250 (2006).","journal-title":"N. Engl. J. Med."},{"key":"BFsrep42676_CR36","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2337\/db11-1516","volume":"61","author":"AH Rosengren","year":"2012","unstructured":"Rosengren, A. H. et al. Reduced insulin exocytosis in human pancreatic beta-cells with gene variants linked to type 2 diabetes. Diabetes 61, 1726\u20131733 (2012).","journal-title":"Diabetes"},{"key":"BFsrep42676_CR37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10519-008-9233-0","volume":"39","author":"Z Bochdanovits","year":"2009","unstructured":"Bochdanovits, Z. et al. A Functional polymorphism under positive evolutionary selection in ADRB2 is associated with human intelligence with opposite effects in the young and the elderly. Behav. Genet. 39, 15\u201323 (2009).","journal-title":"Behav. Genet."},{"key":"BFsrep42676_CR38","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s10519-012-9570-x","volume":"43","author":"DM Lyall","year":"2013","unstructured":"Lyall, D. M. et al. ADRB2, brain white matter integrity and cognitive ageing in the Lothian Birth Cohort 1936. Behav. Genet. 43, 13\u201323 (2013).","journal-title":"Behav. Genet."},{"key":"BFsrep42676_CR39","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamapsychiatry.2014.999","volume":"71","author":"I Liberzon","year":"2014","unstructured":"Liberzon, I. et al. Interaction of the ADRB2 gene polymorphism with childhood trauma in predicting adult symptoms of posttraumatic stress disorder. JAMA Psychiatry 71, 1174\u20131182 (2014).","journal-title":"JAMA Psychiatry"},{"key":"BFsrep42676_CR40","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1124\/pr.108.000612","volume":"60","author":"D Rosskopf","year":"2008","unstructured":"Rosskopf, D. & Michel, M. C. Pharmacogenomics of G protein-coupled receptor ligands in cardiovascular medicine. Pharmacol. Rev 60, 513\u2013535 (2008).","journal-title":"Pharmacol. Rev"},{"key":"BFsrep42676_CR41","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.mp.4001940","volume":"12","author":"K Cheslack-Postava","year":"2007","unstructured":"Cheslack-Postava, K. et al. beta2-Adrenergic receptor gene variants and risk for autism in the AGRE cohort. Mol. Psychiatry 12, 283\u2013291 (2007).","journal-title":"Mol. Psychiatry"},{"key":"BFsrep42676_CR42","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1023\/A:1021055617738","volume":"33","author":"B Freeman","year":"2003","unstructured":"Freeman, B. et al. DNA from buccal swabs recruited by mail: evaluation of storage effects on long-term stability and suitability for multiplex polymerase chain reaction genotyping. Behav. Genet. 33, 67\u201372 (2003).","journal-title":"Behav. Genet"},{"key":"BFsrep42676_CR43","doi-asserted-by":"crossref","first-page":"e322","DOI":"10.1038\/tp.2013.95","volume":"3","author":"ML Ancelin","year":"2013","unstructured":"Ancelin, M. L. et al. Angiotensin-converting enzyme gene variants are associated with both cortisol secretion and late-life depression. Transl. Psychiatry 3, e322 (2013).","journal-title":"Transl. Psychiatry"},{"key":"BFsrep42676_CR44","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","volume":"41","author":"JC Lambert","year":"2009","unstructured":"Lambert, J. C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease. Nat. Genet. 41, 1094\u20131099 (2009).","journal-title":"Nat. Genet."},{"key":"BFsrep42676_CR45","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrd3024","volume":"9","author":"S Rajagopal","year":"2010","unstructured":"Rajagopal, S., Rajagopal, K. & Lefkowitz, R. J. Teaching old receptors new tricks: biasing seven-transmembrane receptors. Nat. Rev. Drug. Discov 9, 373\u2013386 (2010).","journal-title":"Nat. Rev. Drug. Discov"},{"key":"BFsrep42676_CR46","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0006-3223(02)01672-4","volume":"52","author":"JM Kent","year":"2002","unstructured":"Kent, J. M., Mathew, S. J. & Gorman, J. M. Molecular targets in the treatment of anxiety. Biol. Psychiatry 52, 1008\u20131030 (2002).","journal-title":"Biol. Psychiatry"},{"key":"BFsrep42676_CR47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrg2164","volume":"8","author":"GS Wang","year":"2007","unstructured":"Wang, G. S. & Cooper, T. A. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat. Rev. Genet 8, 749\u2013761 (2007).","journal-title":"Nat. Rev. Genet"},{"key":"BFsrep42676_CR48","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1097\/FPC.0b013e328333dae6","volume":"20","author":"AA Litonjua","year":"2010","unstructured":"Litonjua, A. A. et al. Very important pharmacogene summary ADRB2. Pharmacogenet. Genom 20, 64\u201369 (2010).","journal-title":"Pharmacogenet. Genom"},{"key":"BFsrep42676_CR49","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/aje\/kwi184","volume":"162","author":"A Thakkinstian","year":"2005","unstructured":"Thakkinstian, A. et al. Systematic review and meta-analysis of the association between \u03b22-adrenoceptor polymorphisms and asthma: a HuGE review. Am. J. Epidemiol. 162, 201\u2013211 (2005).","journal-title":"Am. J. Epidemiol."},{"key":"BFsrep42676_CR50","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500393","volume":"7","author":"MR Taylor","year":"2007","unstructured":"Taylor, M. R. Pharmacogenetics of the human beta-adrenergic receptors. Pharmacogenomics. J 7, 29\u201337 (2007).","journal-title":"Pharmacogenomics. J"},{"key":"BFsrep42676_CR51","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1038\/mp.2012.37","volume":"17","author":"M Ayalew","year":"2012","unstructured":"Ayalew, M. et al. Convergent functional genomics of schizophrenia: from comprehensive understanding to genetic risk prediction. Mol. Psychiatry 17, 887\u2013905 (2012).","journal-title":"Mol. Psychiatry"},{"key":"BFsrep42676_CR52","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jpsychires.2007.02.008","volume":"42","author":"K Huang","year":"2008","unstructured":"Huang, K. et al. No association found between the promoter variants of ADRA1A and schizophrenia in the Chinese population. J. Psychiatr. Res. 42, 384\u2013388 (2008).","journal-title":"J. Psychiatr. Res."},{"key":"BFsrep42676_CR53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S1415-47572014000100005","volume":"37","author":"LF Saliba","year":"2014","unstructured":"Saliba, L. F. et al. Obesity-related gene ADRB2, ADRB3 and GHRL polymorphisms and the response to a weight loss diet intervention in adult women. Genet. Mol. Biol. 37, 15\u201322 (2014).","journal-title":"Genet. Mol. Biol."},{"key":"BFsrep42676_CR54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ajmg.b.30355","volume":"144","author":"D Clark","year":"2007","unstructured":"Clark, D., Mata, I., Kerwin, R., Munro, J. & Arranz, M. No association between ADRA2A polymorphisms and schizophrenia. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 144, 341\u2013343 (2007).","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet"},{"key":"BFsrep42676_CR55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ajmg.b.30292","volume":"141B","author":"I Burcescu","year":"2006","unstructured":"Burcescu, I. et al. Association study of the adrenergic receptors and childhood-onset mood disorders in Hungarian families. Am. J. Med. Genet. B. Neuropsychiatr. Genet. 141B, 227\u2013233 (2006).","journal-title":"Am. J. Med. Genet. B. Neuropsychiatr. Genet"},{"key":"BFsrep42676_CR56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/00001756-199805110-00006","volume":"9","author":"K Ohara","year":"1998","unstructured":"Ohara, K., Nagai, M., Tani, K., Tsukamoto, T. & Suzuki, Y. Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders. Neuroreport 9, 1291\u20131294 (1998).","journal-title":"Neuroreport"},{"key":"BFsrep42676_CR57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1006\/mgme.2000.3015","volume":"71","author":"DE Comings","year":"2000","unstructured":"Comings, D. E. & MacMurray, J. P. Molecular heterosis: a review. Mol. Genet. Metab. 71, 19\u201331 (2000).","journal-title":"Mol. Genet. Metab."},{"key":"BFsrep42676_CR58","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/thorax.58.8.703","volume":"58","author":"L Joos","year":"2003","unstructured":"Joos, L. et al. Polymorphisms in the beta2 adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers. Thorax 58, 703\u2013707 (2003).","journal-title":"Thorax"},{"key":"BFsrep42676_CR59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.psychres.2015.04.034","volume":"228","author":"TA Durham","year":"2015","unstructured":"Durham, T. A. et al. Posttraumatic stress disorders dysphoria dimension and relations with generalized anxiety disorder symptoms. Psychiatry. Res. 228, 150\u2013155 (2015).","journal-title":"Psychiatry. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep42676","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep42676.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T20:09:56Z","timestamp":1671826196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep42676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,15]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,12]]}},"alternative-id":["BFsrep42676"],"URL":"https:\/\/doi.org\/10.1038\/srep42676","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,15]]},"assertion":[{"value":"2 October 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42676"}}